{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:34:45Z","timestamp":1794044085799,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.rmed.2025.108178","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:29:33Z","timestamp":1747999773000},"page":"108178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Change in the 6-min walk test among 71 patients with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacaftor"],"prefix":"10.1016","volume":"244","author":[{"given":"Julien","family":"Perrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Rabilloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.rmed.2025.108178_bib1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199212173272504","article-title":"The prognostic value of exercise testing in patients with cystic fibrosis","volume":"327","author":"Nixon","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108178_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2021.11.011","article-title":"Exercise intolerance in cystic fibrosis-the role of CFTR modulator therapies","volume":"21","author":"Caterini","year":"2022","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.rmed.2025.108178_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0008-6363(95)00245-6","article-title":"CFTR chloride channels in human and simian heart","volume":"31","author":"Warth","year":"1996","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.rmed.2025.108178_bib4","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.21982","article-title":"Cystic fibrosis transmembrane conductance regulator in human muscle: dysfunction causes abnormal metabolic recovery in exercise","volume":"67","author":"Lamhonwah","year":"2010","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108178_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12890-019-0866-y","article-title":"Lumacaftor\/Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction","volume":"19","author":"Wark","year":"2019","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108178_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2020.12.006","article-title":"VO2max as an exercise tolerance endpoint in people with cystic fibrosis: lessons from a lumacaftor\/ivacaftor trial","volume":"20","author":"Wilson","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"5","key":"10.1016\/j.rmed.2025.108178_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e26729","article-title":"One year effect of tezacaftor and ivacaftor on functional exercise capacity and muscle strength in people with cystic fibrosis","volume":"10","author":"Anne-Sophie","year":"2024","journal-title":"Heliyon"},{"issue":"10212","key":"10.1016\/j.rmed.2025.108178_bib8","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor\/tezacaftor\/ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.rmed.2025.108178_bib9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108178_bib10","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/crj.12763","article-title":"Static hyperinflation is associated with ventilatory limitation and exercise tolerance in adult cystic fibrosis","volume":"12","author":"Stevens","year":"2018","journal-title":"Clin. Res. J"},{"issue":"1","key":"10.1016\/j.rmed.2025.108178_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108178_bib12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1183\/09031936.00150414","article-title":"An official systematic review of the European Respiratory Society\/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease","volume":"44","author":"Singh","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2025.108178_bib13","first-page":"1610","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest (Am. Coll. Chest Physicians)"},{"issue":"5","key":"10.1016\/j.rmed.2025.108178_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.rmed.2025.108178_bib15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/genes12081178","article-title":"Effectiveness of Elexacaftor\/Tezacaftor\/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del\/Unknown and Advanced Lung Disease","volume":"12","author":"Terlizzi","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.rmed.2025.108178_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106646","article-title":"Effectiveness and safety of elexacaftor\/tezacaftor\/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del\/minimal function genotype","volume":"189","author":"Carnovale","year":"2021","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108178_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/genes14020449","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor on cardiorespiratory polygraphy parameters and respiratory muscle strength in cystic fibrosis patients with severe lung disease","volume":"14","author":"Giallongo","year":"2023","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.rmed.2025.108178_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ppul.26243","article-title":"Effect of Trikafta on bone density, body composition and exercise capacity in CF: a pilot study","volume":"58","author":"Gur","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2025.108178_bib19","doi-asserted-by":"crossref","DOI":"10.23866\/BRNRev:2017-0024","article-title":"Exercise testing to evaluate therapeutic interventions in chronic respiratory diseases","volume":"4","author":"Puente-Maestu","year":"2018","journal-title":"Barcelona Respir. Network"},{"issue":"1","key":"10.1016\/j.rmed.2025.108178_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2022.08.018","article-title":"Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor\/tezacaftor\/ivacaftor","volume":"22","author":"Fajac","year":"2023","journal-title":"J. Cyst. Fibros."},{"issue":"169","key":"10.1016\/j.rmed.2025.108178_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0029-2023","article-title":"Guidance and standard operating procedures for functional exercise testing in cystic fibrosis","volume":"32","author":"Saynor","year":"2023","journal-title":"Eur. Respir. Rev."},{"issue":"10","key":"10.1016\/j.rmed.2025.108178_bib22","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.rmed.2006.02.004","article-title":"The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis","volume":"100","author":"Lettieri","year":"2006","journal-title":"Respir. Med."},{"issue":"9","key":"10.1016\/j.rmed.2025.108178_bib23","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.21037\/jtd.2017.08.53","article-title":"Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis","volume":"9","author":"Hsieh","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"9","key":"10.1016\/j.rmed.2025.108178_bib24","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.rmed.2015.06.013","article-title":"Prognostic value of variables derived from the six-minute walk test in patients with COPD: results from the ECLIPSE study","volume":"109","author":"Andrianopoulos","year":"2015","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108178_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ppul.21125","article-title":"Does the 6-min walk test correlate with the exercise stress test in children?","volume":"45","author":"Lesser","year":"2010","journal-title":"Pediatr. Pulmonol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108178_bib26","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1038\/s41598-024-59622-2","article-title":"Elexacaftor\/tezacaftor\/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis","volume":"14","author":"Westh\u00f6lter","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.rmed.2025.108178_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4187\/respcare.01946","article-title":"Static hyperinflation is associated with decreased peak exercise performance in children with cystic fibrosis","volume":"58","author":"Sovtic","year":"2013","journal-title":"Respir. Care"},{"issue":"6","key":"10.1016\/j.rmed.2025.108178_bib28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcf.2013.04.010","article-title":"Prognostic relevance of dynamic hyperinflation during cardiopulmonary exercise testing in adult patients with cystic fibrosis","volume":"12","author":"Stevens","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2025.108178_bib29","doi-asserted-by":"crossref","unstructured":"Gramegna A, Alicandro G, Premuda C, et al. Relationship between lung volumes and heterogeneity in the response to elexacaftor\/tezacaftor\/ivacaftor in patients with cystic fibrosis and advanced lung disease. Chest (Am. Coll. Chest Physicians). Published online March 2024:S0012369224004045. doi:10.1016\/j.chest.2024.03.033.","DOI":"10.1016\/j.chest.2024.03.033"},{"key":"10.1016\/j.rmed.2025.108178_bib30","doi-asserted-by":"crossref","unstructured":"Philipsen LKD, Olesen HV, Jensen JH, et al. Changes in exercise capacity in people with Cystic Fibrosis after one year of Elexacaftor\/Tezacaftor\/Ivacaftor treatment \u2013 a Danish prospective cohort. J. Cyst. Fibros. Published online May 2024:S1569199324000559. doi:10.1016\/j.jcf.2024.04.010.","DOI":"10.1016\/j.jcf.2024.04.010"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:16:34Z","timestamp":1762337794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125002409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"alternative-id":["S0954611125002409"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108178","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in the 6-min walk test among 71 patients with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacaftor","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108178"}}